Tiffany Burt

Vice President, Head of Commercial at ProQR Therapeutics NV

Tiffany Burt

Tiffany Burt

Vice President, Head of Commercial at ProQR Therapeutics NV

Overview
RelSci Relationships

141

Relationships
RelSci Relationships are individuals Tiffany Burt likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at ProQR Therapeutics NV

Relationship likelihood: Strong

Chief Executive Officer at ProQR Therapeutics NV

Relationship likelihood: Strong

Chief Financial & Business Officer at ProQR Therapeutics NV

Relationship likelihood: Strong

Chief Medical Officer at ProQR Therapeutics NV

Relationship likelihood: Strong

Former Chief Corporate Development Officer & General Counsel at ProQR Therapeutics NV

Relationship likelihood: Average

Director-Investor Relations at ProQR Therapeutics NV

Relationship likelihood: Average

Director-Corporate Communications at ProQR Therapeutics NV

Relationship likelihood: Average

Former Senior Director-Global Respiratory at Gilead Sciences, Inc.

Relationship likelihood: Average

Executive Vice President-Research & Development at ProQR Therapeutics NV

Relationship likelihood: Average

Former Chief People & Organization Officer at ProQR Therapeutics NV

Relationship likelihood: Average

Paths to Tiffany Burt
Potential Connections via
Relationship Science
You
Tiffany Burt
Vice President, Head of Commercial at ProQR Therapeutics NV
Career History
Vice President, Head of Commercial
2018 - Current

ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Associate Director
Prior

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.

Other Affiliations

Tiffany Burt is affiliated with ProQR Therapeutics NV, ARIAD Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tiffany Burt. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tiffany Burt's profile does not indicate a business or promotional relationship of any kind between RelSci and Tiffany Burt.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/tiffany-burt-222335064
  • https://relationshipscience.com/person/tiffany-burt-222335064